FDA
Home Page | CDRH Home Page | Search
| CDRH
A-Z Index | Contact CDRH
|
Assignment of Review Documents
|
August 24, 1990 Assignment of Review Documents Purpose. The purpose of this memorandum is to set forth procedures for the assignment of review documents (PMAs, PMA supplements and amendments, IDEs, IDE supplements and amendments, and 510(k)s) to ODE staff. It also covers reassignment of such documents from primary reviewers to other reviewers. Accordingly, this memorandum supersedes and replaces Integrity Memorandum #I89-2, entitled "Reassignment of Review Documents". Assignment of Review Documents. Review documents may be assigned by the Branch Chief or the Division Director to a specific reviewer based on the following factors: - the professional or scientific expertise of that reviewer is required for the device that is the subject of the submission; - the reviewer has previous experience and knowledge of the issues related to that submission; - that reviewer has reviewed prior submissions, e.g., an earlier IDE for that device; - the reviewer to whom the application is assigned is the reviewer most familiar with that manufacturer's submissions; - the workload of other reviewers in the branch is proportionately greater than the workload of the reviewer to whom the assignment is-being made; or, - the assignment of the submission will offer a special training experience to the reviewer who otherwise might not have such an opportunity. Reassignment of Review Documents. Whenever a review document is reassigned from the primary reviewer to another reviewer, who will be the new primary reviewer, the supervisor making the reassignment shall include, in that document's folder, a statement of the reasons for the reassignment. All such reassignments must have the concurrence of the Division Director, who should initial the written explanation of the reassignment. There are many valid reasons for reassignment. For example, the primary reviewer may be going on extended leave and the document cannot wait for the reviewer's return. Collateral Reviews. You should keep in mind that these procedures, as they relate to assignment and reassignment or review documents, do not apply to the referral of a document to another ODE reviewer or to another office within the Center for scientific, professional, or other special review, e.g., referral of the document to the Office of Science and Technology for review, if the document will be returned to the original, primary reviewer for completion. We do not want this policy to interfere with the "team approach": to document review. Any specialized review that is necessary should be obtained. Document Transfers. This policy also does not apply to the transfer of a document to another office outside of the Center. For example, if a document applies to a product that is determined to be a drug, the document would be transferred to the CDER and it would be logged out of ODE via another mechanism by the appropriate POS staff. Program Operation Staff. This memorandum does not apply to reassignments within the POS staff offices which provide oversight and quality control reviews and which do not provide primary document reviews. Effective Date This policy is effective immediately.
Updated 5/30/1996
CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page
Center for Devices and Radiological Health / CDRH